Fjarde Ap Fonden Bio Rad Laboratories, Inc. Transaction History
Fjarde Ap Fonden
- $9.89 Billion
- Q4 2024
A detailed history of Fjarde Ap Fonden transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Fjarde Ap Fonden holds 3,480 shares of BIO stock, worth $908,941. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,480
Previous 2,280
52.63%
Holding current value
$908,941
Previous $763,000
49.8%
% of portfolio
0.01%
Previous 0.01%
Shares
16 transactions
Others Institutions Holding BIO
# of Institutions
478Shares Held
19.2MCall Options Held
15.7KPut Options Held
11.5K-
Vanguard Group Inc Valley Forge, PA1.92MShares$501 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$405 Million0.01% of portfolio
-
Wealthfront Advisers LLC1.04MShares$272 Million0.29% of portfolio
-
Veritas Asset Management LLP977KShares$255 Million3.36% of portfolio
-
Dimensional Fund Advisors LP Austin, TX746KShares$195 Million0.06% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $6.43B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...